A detailed history of Fora Capital, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Fora Capital, LLC holds 29,263 shares of FOLD stock, worth $287,947. This represents 0.04% of its overall portfolio holdings.

Number of Shares
29,263
Holding current value
$287,947
% of portfolio
0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$9.55 - $12.09 $279,461 - $353,789
29,263 New
29,263 $312,000
Q1 2021

May 17, 2021

SELL
$9.2 - $23.86 $146,445 - $379,803
-15,918 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$13.47 - $24.89 $214,415 - $396,199
15,918 New
15,918 $367,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.76B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.